← Leaderboards
Imad Al Ghouleh
University Of Pittsburgh At Pittsburgh
$1,947,775
Attributed
$1,947,775
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $389.6K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,947,775 · 1
By mechanism
R01$1,947,775 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Harry C. Blair$6,272,214
- Paul H Schlesinger$3,228,187
- Deborah J. Nelson$14,424,393
- Peter A Friedman$14,125,747
- Bruce Robert Pitt$8,182,501
Others in their field
Other Emerging Leaders on “Animal Model”
- Ted Ross · University Of Georgia$71,962,304
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,644,409
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Gary Fanger · Rise Therapeutics, Llc$16,982,327
Research focus
Animal ModelAreaAttenuatedAttenuationBindingBiochemicalBlocking AntibodiesBlood VesselsCellsCombinatorialDesignDisease ModelDisease ProgressionDown-RegulationDrug DevelopmentEndothelial CellsEndotheliumErm ProteinEtiologyExperimental StudyFailureFda ApprovedFutureAffect
Grant awards (5)
Endothelial Reprogramming in Pulmonary Hypertension$389,555
R01 · FY2023 · HL · contact PI
Endothelial Reprogramming in Pulmonary Hypertension$389,555
R01 · FY2022 · HL · contact PI
Endothelial Reprogramming in Pulmonary Hypertension$389,555
R01 · FY2021 · HL · contact PI
Endothelial Reprogramming in Pulmonary Hypertension$389,555
R01 · FY2020 · HL · contact PI
Endothelial Reprogramming in Pulmonary Hypertension$389,555
R01 · FY2019 · HL · contact PI